Repurposing clinically approved drugs as Wee1 checkpoint kinase inhibitors: an in silico investigation integrating molecular docking, ensemble QSAR modelling and molecular dynamics simulation
2022Molecular SimulationJournal
10.1080/08927022.2022.2101673Full text3 citations